These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8242578)

  • 21. In-111 CYT-103 immunoscintigraphy in the imaging of ovarian carcinoma.
    Neal CE; Baker MR; Hilgers RD; Fanning J; Burke RC; Snodgrass J; Cull RD
    Clin Nucl Med; 1993 Jun; 18(6):472-6. PubMed ID: 8319398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between 131I and 111In as radiolabels for monoclonal antibodies in immunoscintigraphy of tumor bearing nude mice.
    Thedrez P; Blottiere H; Chatal JF; Grzyb J; Douillard JY
    Tumour Biol; 1986; 7(2-3):137-45. PubMed ID: 3797961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.
    Raderer M; Becherer A; Kurtaran A; Angelberger P; Li S; Leimer M; Weinlaender G; Kornek G; Kletter K; Scheithauer W; Virgolini I
    J Nucl Med; 1996 Sep; 37(9):1480-7. PubMed ID: 8790198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.
    Neal CE; Swan TL; Baker MR; Ellis RL; Katterhagen JG
    Gastrointest Radiol; 1991; 16(3):251-5. PubMed ID: 1879645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superiority of SPET to planar imaging in the detection of colorectal carcinomas with 111In monoclonal antibodies.
    Nabi HA; Erb DA; Cronin VR
    Nucl Med Commun; 1995 Aug; 16(8):631-9. PubMed ID: 7491174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
    Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O
    Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of radioimmunoscintigraphy on the management of colorectal and ovarian cancer patients: a retrospective study.
    Blend MJ; Bhadkamkar VA
    Cancer Invest; 1998; 16(7):431-41. PubMed ID: 9774949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunodetection of human colon cancer in nude mice by a new monoclonal antibody A7 against human colorectal cancer.
    Kojima S; Shimura N; Kubodera A; Kubota K; Takahashi T; Oyamada H
    Int J Rad Appl Instrum B; 1991; 18(8):847-53. PubMed ID: 1800460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiolabeled antibody imaging in the management of colorectal cancer. Results of a multicenter clinical study.
    Doerr RJ; Abdel-Nabi H; Krag D; Mitchell E
    Ann Surg; 1991 Aug; 214(2):118-24. PubMed ID: 1867518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.
    Pinkas L; Robins PD; Forstrom LA; Mahoney DW; Mullan BP
    Nucl Med Commun; 1999 Aug; 20(8):689-96. PubMed ID: 10451876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative gamma detection probe with presurgical antibody imaging in colon cancer.
    Kuhn JA; Corbisiero RM; Buras RR; Carroll RG; Wagman LD; Wilson LA; Yamauchi D; Smith MM; Kondo R; Beatty JD
    Arch Surg; 1991 Nov; 126(11):1398-403. PubMed ID: 1747053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical utility of immunoscintigraphy in managing ovarian cancer.
    Krag DN
    J Nucl Med; 1993 Mar; 34(3 Suppl):545-8. PubMed ID: 8441055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
    McKearn TJ
    Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunoscintigraphy of colorectal carcinoma with a 111In-labelled anti-TAG-72 monoclonal antibody.
    Muxí A; Pons F; Herranz R; Novell F; Fernández R; Filella X; García A; Solá M; Trías M; Setoain J
    Nucl Med Commun; 1993 Sep; 14(9):775-87. PubMed ID: 8233243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
    Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
    Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunodetection of colorectal carcinoma.
    Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
    Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
    Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
    J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.